Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.065 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |